🔎 Trials Near Me

Akèy › Maladi Entestinal Anflamatwa › Florid › Orlando

Etid klinik pou Maladi Entestinal Anflamatwa nan Orlando, FL

8 etid pou Maladi Entestinal Anflamatwa ap chèche patisipan nan sit nan ak bò kote Orlando (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis

Ap rekriteFaz 2
  • Orlando Health Digestive Health Institute, Orlando
  • AdventHealth Orlando, Orlando
  • Novum Research, LLC, Clermont · 24 mi lwen
Laj 18 a 75 · Tout sèks · Mizajou Sep 30, 2026 · NCT06598943

Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis

Ap rekriteFaz 1/2Volontè an sante akeyi
  • Xencor Investigative Site, Kissimmee · 16 mi lwen
Laj 18 a 75 · Tout sèks · Mizajou Sep 29, 2026 · NCT06619990

A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

Ap rekriteFaz 2
  • Site 007, Kissimmee · 16 mi lwen
Laj 18 a 75 · Tout sèks · Mizajou Sep 29, 2026 · NCT07012395

A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis

Ap rekriteFaz 2
  • Site US-026, Orlando
Laj 18 a 75 · Tout sèks · Mizajou Sep 29, 2026 · NCT07845487

Study of DISC-0974-201 in Participants With IBD and Anemia

Ap rekriteFaz 2
  • Clinical Research of Osceola, LLC, Kissimmee · 16 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT07368972

A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease

Ap rekriteFaz 2
  • Endoscopic Research Inc, Orlando
  • Clinical Research of Osceola, Kissimmee · 16 mi lwen
Laj 18 a 85 · Tout sèks · Mizajou Sep 22, 2026 · NCT06226883

Zymfentra (Infliximab-dyyb) REal World Cohort STudy

Ap rekriteEtid obsèvasyon
  • AdventHealth, Orlando
Laj 18 ak plis · Tout sèks · Mizajou Aug 5, 2026 · NCT07237516

A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease

Ap rekriteFaz 2
  • Mirador Therapeutics Selected Site, Orlando
Laj 18 a 80 · Tout sèks · Mizajou Mar 12, 2026 · NCT07113522

Etid Maladi Entestinal Anflamatwa nan lòt vil

Lòt etid nan Orlando

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.